Immunophenotypic Analysis of Tissues by Flow Cytometry
Flow cytometry immunophenotypic analysis is a method of testing in which cells from a suspected neoplasm are placed in suspension in the presence of various fluorescent-labeled antibodies then passed in single file by lasers that record the characteristics of the cells at the same time it records the presence of fluorescence indicative of a specific antibody. The suspect cells must be capable of being placed in a suspension individually in order to flow adequately. Multiple sets of cells are run, each with different antibodies, until a panel of reactivities is obtained. The result is a list of cells positive for each antibody (and therefore having the corresponding antigen, usually denoted by a Cluster Designation or CD number) along with percentages for each antibody, sorted by cell size.
This raw data is then processed by specialized computer software and interpreted by a pathologist who can also vary the "gates," or sorting criteria used, either by size or antibody reactivity or both. The profile created by this process is characteristic of a given hematopoietic neoplasm or a given cellular characteristic. This test is best suited to hematopoietic (blood derived) or lymphoid (lymph node derived) processes. Solid tumors in general do not work well due primarily to the adhesiveness of the tumor cells to each other which does not allow them to be separated and flow in a single file as is required for optimal utility. The test is not limited to neoplasms; it can be used for any process in which cells can be held in suspension individually and marked by specific fluorescent-labeled antibodies. This includes, but is not restricted to, analyzing maternal blood for hemoglobin F to detect fetomaternal hemorrhage and analyzing red blood cells for loss of CD55 to detect Paroxysmal Nocturnal Hemogloboinuria.
The test is not useful to detect Hodgkin’s lymphoma due to the scarcity of diagnostic malignant cells. It also may yield a false negative in cases of large B-cell lymphoma. It requires viable, non-necrotic tissues. It works very well with body fluids and blood from bone marrow aspirates as well as peripheral blood. There are occasional cases in which flow cytometry fails to demonstrate clonality in a suspected malignancy; in such a case material can be submitted for gene rearrangement studies.
- As an aid in diagnosis of hematopoietic, lymphoid, and myeloid neoplasms such as acute lymphocytic leukemia, acute myelogenous leukemia, and non-Hodgkin’s lymphoma
Reference ranges vary for the process in question. For example, if a suspected lymphoid malignancy shows only kappa light chain on the suspect cells by flow cytometry, this is diagnostic of a clonal process and consistent with non-Hodgkin’s lymphoma.
Material for full flow cytometry must be fresh and placed in a preservative such as RPMI or Tissue Transport Media (TTM). If viable diagnostic material is obtained, the amount of material needed is relatively small, no more than 1cc of blood and 0.5 cc of viable tissue. For DNA studies, paraffin embedded material may be used. Body fluids should also be placed in RPMI or TTM in a 50/50 ratio. Frozen tissue may also be used.
- Bone Marrow of Multiorgan Donors Underutilized: Implications for Improvement of Accessibility of Hematopoietic Cells for Transplantations. Transplantation. 2011 Dec 8. [PMID: 22158516]
- Am J Clin Pathol. 1998; 110(3): 341-6. [PMID: 9728609]
- Clin Lab Med. 1993; 13(4): 831-52. [PMID: 8313684]
- Clin Lab Med. 1992; 12(2): 237-75. [PMID: 1611820]
- J Clin Pathol. 2000; 53(7): 513-7. [PMID: 10961174]
- Cytometry. 1997; 30(5): 214-30. [PMID: 9383095]